Bank of New York Mellon »

Generate Biomedicines Ord shares owned by Bank of New York Mellon

Quarter-by-quarter ownership of Generate Biomedicines Ord (GENB) shares owned by Bank of New York Mellon from 13F filings

Historical chart of Bank of New York Mellon investment in Generate Biomedicines Ord

Tip: Access up to 7 years of quarterly data

All positions including Generate Biomedicines Ord held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Generate Biomedicines Ord by Bank of New York Mellon

Quarter filed Position value Share count Share price at filing
2026-06-30 $967k 57k 16.87

More positions owned by Bank of New York Mellon

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Inc-cl A Cap (GOOGL)
Broadcom (AVGO)
Ishares Core S&p 500 Etf Core (IVV)
Alphabet Inc-cl C Cap (GOOG)
Micron Technology (MU)
Meta Platforms Inc-class A Cl A (META)
JPMorgan Chase & Co. (JPM)
Tesla Motors (TSLA)
Advanced Micro Devices (AMD)
Eli Lilly & Co. (LLY)
Johnson & Johnson (JNJ)

View all positions for Bank of New York Mellon

Top funds holding Generate Biomedicines Ord

Flagship Ventures Management
FMR
Capital World Investors
Braidwell
T. Rowe Price Associates
Norges Bank Investment Management
Arch Venture Corp
HarbourVest Partners
BlackRock
Baker Bros. Advisors
Jpmorgan Chase & Co
Deep Track Capital
ARK Investment Management
Vanguard Capital Management
Harvard Management Company

View all funds holding Generate Biomedicines Ord